Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Antonelli

Showing results (201-210 of 246) with videos related to

Pageof 25
Sort By:
Journal of Interferon Research|August 1, 1994
Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patientsG Antonelli, G Giannelli, M Pistello, et al.
Journal of Viral Hepatitis|November 25, 2003
Occult hepatitis C virus infection in type II mixed cryoglobulinaemiaM Casato, D Lilli, G Donato, et al.
Journal of the Neurological Sciences|October 20, 1999
Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1bG Antonelli, E Simeoni, F Bagnato, et al.
Hepatology (Baltimore, Md.)|March 1, 1995
Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and managementL Roffi, G C Mels, G Antonelli, et al.
Journal of Chemotherapy (Florence, Italy)|July 23, 2009
The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovirG d'Ettorre, G Ceccarelli, O Turriziani, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 20, 1999
Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodiesG C Viscomi, G Antonelli, C Bruno, et al.
Journal of Virology|November 17, 2001
Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infectionF Maggi, M Pistello, M Vatteroni, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 20, 2011
Virological and clinical characterization of respiratory infections in children attending an emergency department during the first autumn-winter circulation of pandemic A (H1N1) 2009 influenza virusA Pierangeli, C Scagnolari, C Selvaggi, et al.
The New Microbiologica|January 14, 2005
P-glycoprotein expression affects the intracellular concentration and antiviral activity of the protease inhibitor saquinavir in a T cell lineA Maffeo, F Bellomi, I Solimeo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 27, 2015
Frequent detection of high human papillomavirus DNA loads in oral potentially malignant disordersA Pierangeli, F Cannella, C Scagnolari, et al.
Pageof 25

Showing results (201-210 of 246) with videos related to

Sort By:
Pageof 25
Journal of Interferon Research|August 1, 1994
Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patientsG Antonelli, G Giannelli, M Pistello, et al.
Journal of Viral Hepatitis|November 25, 2003
Occult hepatitis C virus infection in type II mixed cryoglobulinaemiaM Casato, D Lilli, G Donato, et al.
Journal of the Neurological Sciences|October 20, 1999
Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1bG Antonelli, E Simeoni, F Bagnato, et al.
Hepatology (Baltimore, Md.)|March 1, 1995
Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and managementL Roffi, G C Mels, G Antonelli, et al.
Journal of Chemotherapy (Florence, Italy)|July 23, 2009
The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovirG d'Ettorre, G Ceccarelli, O Turriziani, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 20, 1999
Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodiesG C Viscomi, G Antonelli, C Bruno, et al.
Journal of Virology|November 17, 2001
Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infectionF Maggi, M Pistello, M Vatteroni, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 20, 2011
Virological and clinical characterization of respiratory infections in children attending an emergency department during the first autumn-winter circulation of pandemic A (H1N1) 2009 influenza virusA Pierangeli, C Scagnolari, C Selvaggi, et al.
The New Microbiologica|January 14, 2005
P-glycoprotein expression affects the intracellular concentration and antiviral activity of the protease inhibitor saquinavir in a T cell lineA Maffeo, F Bellomi, I Solimeo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 27, 2015
Frequent detection of high human papillomavirus DNA loads in oral potentially malignant disordersA Pierangeli, F Cannella, C Scagnolari, et al.
Pageof 25